Letter to our shareholders - June 2019
"The health sector is in great need of innovations, & will continue to be for a long time yet" says Philippe Genne, CEO & founder, Oncodesign Biotechnology.
Letters to Shareholders
Letter to our shareholders - November 2018
"I urge you all to stay aboard and keep your eyes firmly fixed on the future: we believe in it" says Philippe Genne, CEO & founder, Oncodesign Biotechnology.
Letter to our shareholders - June 2018
"Step by step, we are building our future with innovation" says Philippe Genne, CEO & founder, Oncodesign Biotechnology.
